Nardine Nakhla

Dr. Nardine Nakhla

University of Waterloo, School of Pharmacy
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Clinical Therapeutics
Verified
Journal Article
Closed access
LMLuc Martinez
Luc Martinez
EEEvan Ekman
Evan Ekman
Nardine NakhlaNardine Nakhla
Nardine Nakhla

1 July 2024 in Canadian Family Physician
Verified
Journal Article
Open access
PDF file
Nardine NakhlaNardine Nakhla
Nardine Nakhla
VLValerie Leung
Valerie Leung
KSKevin L. Schwartz
Kevin L. Schwartz
While no universal definition of minor ailments exists, they are often described as health conditions that can be reliably self-diagnosed by a patient and managed with self-care strategies (eg, nonprescription therapeutics, non-pharmacologic therapy) or with minimal treatment using prescription agents.2 This includes conditions that can be managed in the pharmacy and require only minimal or short-term follow-up, such as allergies, uncomplicated urinary tract infections (UTIs), and cold sores.2

29 March 2021 in International Journal of Pharmacy Practice
Verified
Journal Article
Open access
PDF file
JKJohn J Kim
John J Kim
ATAdeline H Tian
Adeline H Tian
LPLee Pham
Lee Pham
Nardine NakhlaNardine Nakhla
Nardine Nakhla
SHSherilyn K D Houle
Sherilyn K D Houle
MAMhd Wasem Alsabbagh
Mhd Wasem Alsabbagh
Objectives: The objective of this study was to use a decision-analytic model to examine the potential economic impact of establishing a remunerated programme for pharmacists prescribing for minor ailments (PPMA) in Ontario, Canada. Methods: A novel decision tool was developed to assess the economic impact of pharmacists prescribing for upper respiratory tract infections (URTIs), contact dermatitis (CD) and conjunctivitis by performing a cost-minimization analysis from a public payer perspective. Two prescribing strategies were compared: (1) PPMA, where patients may seek care from pharmacists or physicians, and (2) the usual care model (UCM), where all patients receive care from physicians. Two remuneration models for the PPMA strategy were also compared: (1) a prescription-detached scenario (PDS), where pharmacists were remunerated CAD$18.00 for each consultation, and (2) a Prescription-Attached Scenario (PAS), where pharmacists were only remunerated if a decision to prescribe was made. Key findings: At a service uptake rate of 38% for the PDS, the PPMA model led to savings of $7.51, $4.08 and $5.15 per patient for URTIs, CD and conjunctivitis, respectively. Per 30 000 patients, the PPMA model for these minor ailments was projected to lead to cumulative reductions in visits to the emergency department, family physician and walk-in clinics by 799, 3677 and 5090, respectively. Conclusions: The results of the study strongly suggest that enabling community pharmacists to assess and prescribe for minor ailments could potentially lead to large savings for the government in Ontario, Canada. In 100% of the PAS scenarios simulated, pharmacists as prescribers led to cost savings.

1 November 2019 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
KHKaleen N. Hayes
Kaleen N. Hayes
Nardine NakhlaNardine Nakhla
Nardine Nakhla
MTMina Tadrous
Mina Tadrous
Proton pump inhibitors (PPIs) are antiacid secretory agents that are first-line therapy for gastroesophageal reflux disease, peptic ulcer disease, and a wide ra

27 April 2021 in Pharmacy
Verified
Journal Article
Open access
PDF file
Nardine NakhlaNardine Nakhla
Nardine Nakhla
ASAnastasia Shiamptanis
Anastasia Shiamptanis
To date, eight of ten Canadian provinces have authorized pharmacists to prescribe for minor ailments. Prompted by a request by the Ontario Minister of Health, draft regulations were submitted to enable this pharmacy service in Ontario. Differences exist in how jurisdictions have approached development and delivery of these programs. This paper will summarize key differences and similarities among existing programs while highlighting the multi-pronged approach utilized by Ontario. Such an approach involved broad stakeholder engagement, implementation science, and an evaluations framework to guide an assessment of the impact of this new service. These insights can be leveraged by other jurisdictions planning to initiate or evolve their minor ailment prescribing services.

16 December 2020 in Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
Verified
Journal Article
Closed access
PDF file
Nardine NakhlaNardine Nakhla
Nardine Nakhla
EBEmily Black
Emily Black
HAHiba Abdul-Fattah
Hiba Abdul-Fattah
JTJeff Taylor
Jeff Taylor
Self-care instruction in pharmacy curricula is essential given the impact pharmacists have in caring for patients in the community and their evolving role in this area. The primary objective of this study was to strengthen our current understanding of self-care education across undergraduate Canadian pharmacy programs. A national curriculum survey and follow-up phone interview was conducted in 2019 to assess the quantity and quality of self-care instruction across Canadian pharmacy schools. Representatives were selected based on theirparticipation in the Association of Faculties of Pharmacy of Canada Self-Care Therapeutics and Minor Ailments special interest group. Responses were received from all 10 pharmacy schools in Canada. Self-care education varies across Canadian pharmacy curricula, reflecting differences in scopes of practice across provinces, topics of interest and availability of space within curricula by the various faculties. Specifically, there was considerable variability in the number of hours devoted to self-care education, course content and methods for integration and teaching. Results of this study may help inform and evolve self-care curricula across the country. We argue that strategies for enhancing current programs may include establishing a minimum number of core hours and topics, expanding natural health product content and curricular content oversight by a lead faculty member. Can Pharm J (Ott) 2021;154:xx-xx.